Cantor A - Search Results

1

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

Bepler G, Kusmartseva I, Sharma S, Gautam A, Cantor A, Sharma A, Simon G. Bepler G, et al. Among authors: cantor a. J Clin Oncol. 2006 Oct 10;24(29):4731-7. doi: 10.1200/JCO.2006.06.1101. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966686 Clinical Trial.

2

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G. Haura EB, et al. Among authors: cantor a. Clin Cancer Res. 2005 Dec 1;11(23):8288-94. doi: 10.1158/1078-0432.CCR-05-0827. Clin Cancer Res. 2005. PMID: 16322287

3

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

Simon G, Sharma A, Li X, Hazelton T, Walsh F, Williams C, Chiappori A, Haura E, Tanvetyanon T, Antonia S, Cantor A, Bepler G. Simon G, et al. Among authors: cantor a. J Clin Oncol. 2007 Jul 1;25(19):2741-6. doi: 10.1200/JCO.2006.08.2099. J Clin Oncol. 2007. PMID: 17602079 Clinical Trial.

4

Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer.

Bepler G, Sommers KE, Cantor A, Li X, Sharma A, Williams C, Chiappori A, Haura E, Antonia S, Tanvetyanon T, Simon G, Obasaju C, Robinson LA. Bepler G, et al. Among authors: cantor a. J Thorac Oncol. 2008 Oct;3(10):1112-8. doi: 10.1097/JTO.0b013e3181874936. J Thorac Oncol. 2008. PMID: 18827606 Free PMC article. Clinical Trial.

5

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.

Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. Bepler G, et al. Among authors: cantor a. J Clin Oncol. 2004 May 15;22(10):1878-85. doi: 10.1200/JCO.2004.12.002. J Clin Oncol. 2004. PMID: 15143080

6

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.

Simon GR, Sharma S, Cantor A, Smith P, Bepler G. Simon GR, et al. Among authors: cantor a. Chest. 2005 Mar;127(3):978-83. doi: 10.1378/chest.127.3.978. Chest. 2005. PMID: 15764785

7

EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.

Ferraro B, Bepler G, Sharma S, Cantor A, Haura EB. Ferraro B, et al. Among authors: cantor a. J Clin Oncol. 2005 Mar 20;23(9):1921-6. doi: 10.1200/JCO.2005.08.127. J Clin Oncol. 2005. PMID: 15774784

8

Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer.

Ramnath N, Sommers E, Robinson L, Nwogu C, Sharma A, Cantor A, Bepler G. Ramnath N, et al. Among authors: cantor a. Chest. 2005 Nov;128(5):3467-74. doi: 10.1378/chest.128.5.3467. Chest. 2005. PMID: 16304301 Clinical Trial.

9

A global genome damage score predictive of lung cancer patients outcome.

Zheng Z, Cantor A, Bepler G. Zheng Z, et al. Among authors: cantor a. Oncogene. 2006 Jul 27;25(32):4491-4. doi: 10.1038/sj.onc.1209476. Epub 2006 Mar 6. Oncogene. 2006. PMID: 16518406

10

Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.

Fishman MN, Garrett CR, Simon GR, Chiappori AA, Lush RM, Dinwoodie WR, Mahany JJ, Dellaportas AM, Cantor A, Gollerki A, Cohen MB, Sullivan DM. Fishman MN, et al. Among authors: cantor a. Clin Cancer Res. 2006 Jan 15;12(2):523-8. doi: 10.1158/1078-0432.CCR-05-0928. Clin Cancer Res. 2006. PMID: 16428495 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters